Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPSURGE: Rilonacept for Prevention of Gout Flares
NCT01459796Phase 3Terminated
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Nov 2011
- Primary completion
- Jun 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of rilonacept in gout, sponsored by Regeneron Pharmaceuticals. Started Nov 2011; status: terminated.
02
Drugs
rilonacept
03
Conditions
gout
Beyond the preview
Go deeper on NCT01459796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459796.